Form D · Other Technology
MedsEngine LLC
Beavercreek, OH · CIK 0002011302
Offering snapshot reported Feb 20, 2024 · SEC filing
- Reported sold
- $5.8M Offering amount: $5.8M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 23, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 20, 2024 | Initial | $5,795,454 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505568
Certain equity subject to the offering with lesser economic rights is issued in exchange for services. For purposes of this Form D only, all classes of equity subject to the offering are treated as having the same value per unit.
Source: Form D, filed Feb 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Gearhardt | Director, Executive, Promoter |
| Douglas Romer | Director |
| Vishal Soin | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2430 Dayton Xenia Road Suite B
Beavercreek, OH, 45434
Beavercreek, OH, 45434